New managing director for PAN
September 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Creston Health, Jon Linscott, Pan, eric hansen
Creative comms agency PAN has appointed a new managing director in Eric Hansen who replaces the recently-departed Jon Linscott.Reporting in …
Cancer drug gains first early UK access grant
September 17, 2014Research and Development, Sales and Marketing Cancer, NICE, UK, keytruda, oncology, pin, promising
A new type of cell therapy for cancer has become the first to be deemed by the UK government as …
Epic Sciences hires regulatory affairs VP
September 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing epic sciences, paul frieberg
San Diego-based cancer diagnostics firm Epic Sciences has appointed Glen Paul Freiberg as its vice president of regulatory affairs and …
Pfizer partners with MedGenesis on Parkinson’s
September 16, 2014Research and Development, Sales and Marketing Canada, Erich Mohr, MedGenesis, Parkinson's, Parkinson’s, Pfizer, neuroscience
Canadian biotech MedGenesis has entered into an agreement with Pfizer to develop potential treatments for Parkinson’s disease. The privately-held biotech …
Pharma exports in UK help drive the economy
September 16, 2014Manufacturing and Production, Sales and Marketing UK, emerging markets, exports, hsbc, imports, pharma
The UK’s pharmaceutical sector is ‘an export success story’, enjoying a competitive advantage and generating a sizeable trade surplus. This …
Roche should be ‘shamed’ into lowering cancer drug price
September 16, 2014Medical Communications, Sales and Marketing Kadcyla, Margaret Connolly, Roche, Swiss, breast cancer, trastuzumab emtansine
A public petition to force Roche to lower the cost of its costly new breast cancer drug Kadcyla has been …
AstraZeneca teams up with rival Lilly for Alzheimer’s
September 16, 2014Research and Development, Sales and Marketing AZD3293, Alzheimer's, Alzheimer’s, AstraZeneca, BACE, lilly
AstraZeneca and US rival Lilly have signed an agreement to develop a new and experimental pill for the treatment of …
Gilead allows generic prices for Sovaldi
September 16, 2014Manufacturing and Production, Sales and Marketing Gilead, hep C, hepatitis C, sofosbuvir, sovaldi
Gilead will allow Indian generic drug firms to make cheap copies of its new hepatitis C pill Sovaldi in an …
No silver bullet, but a growing arsenal for pharma comms
September 16, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lundbeck, comms, eyeforpharma, mcm, selincro, tim white
Digital strategies in the pharma industry have predominately been a red herring, focussing too much on the novelty of digital …
Tiziana appoints Intercept head to its board
September 16, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing roberto pelliccaiari, tiziana
UK biotech firm Tiziana Life Sciences has confirmed that Professor Roberto Pellicciari is joining its scientific advisory board and will …
UK pharma pays out £150m in drug rebates
September 12, 2014Medical Communications, Sales and Marketing ABPI, PPRS, Roche, emms, rebate
The UK pharma industry has paid £150 million back to the government as part of its rebate to “underwrite the …
FDA panel backs liraglutide for obesity
September 12, 2014Manufacturing and Production, Sales and Marketing Arena Pharmaceuticals, Belviq, Novo Nordisk, Qsymia, Victoza, Vivus, diabetes, obesity
An FDA panel has voted 14-1 to allow a form of Novo Nordisk’s type 2 diabetes treatment Victoza to help …
Google’s Calico takes first steps into research
September 12, 2014Medical Communications, Sales and Marketing AbbVie, P7C3, Parkinson's, Parkinson’s, calico, depression, google, motor neurone disease
Google is finally shifting into gear within the health arena as it signs its first research deal to develop a …
Cerenis announces board chairman
September 12, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cerenis
France and US-based biopharma firm Cerenis Therapeutics has confirmed the appointment of Dr Richard Pasternak as its chairman of the …
Lilly and Boehringer diabetes biosimilar sees EU approval
September 11, 2014Sales and Marketing Boehringer, EU, European Commission, Lantus, Sanofi, diabetes, lilly
Lilly and Boehringer Ingelheim’s insulin glargine product has been shown the green light by the European Commission (EC). The copycat …
FDA approves new indication for Xtandi
September 11, 2014Sales and Marketing Astellas, FDA, Medivation, Xtandi, Zytiga, prostate
The FDA has approved Astellas Pharma and Medivation’s prostate cancer drug Xtandi (enzalutamide) for use in patients who have not …
Fourth diet pill makes it to US market
September 11, 2014Manufacturing and Production, Sales and Marketing Contrave, FDA, Orexigen Therapeutics, diet, obesity
Orexigen Therapeutics has gained FDA approval for its new obesity treatment Contrave to help overweight patients reduce their food intake. …
90TEN Healthcare appoints comms director
September 11, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 90TEN, Lottie Tupholme, Peter Impey, Steve Ramsey
London comms agency 90TEN Healthcare has hired Peter Impey as its director of international communications, and added two heads to …
NICE seeks more trial data from pharma
September 10, 2014Medical Communications, Research and Development, Sales and Marketing David Haslam, NICE, Tamiflu, alltrials, transparency
NICE is calling on pharma to release more data so it can better assess the costs of new medicines.The watchdog …
InterMune’s IPF drug shines at ERS Congress
September 10, 2014Research and Development, Sales and Marketing Boehringer, ERS, Esbriet, IPF, InterMune, idiopathic pulmonary fibrosis, munich, pirfenidone
InterMune has posted positive data for its lung-scarring drug at this year’s European Respiratory Society Annual Congress 2014 (ERS). Pharmafile …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
